SCHEMBL24166602

SCHEMBL24166602

CN1CCN(c2ccc(-c3ccncc3)cc2Nc2ncnc(Cl)c2N)CC1

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 20/20 0.85
KMT2A Q03164 20/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29545444 1.00 WDR5 (0.85) WDR5KMT2A
SCHEMBL24429941 0.92 WDR5 (1.00) WDR5KMT2A
SCHEMBL24166284 0.91 WDR5 (0.86) WDR5KMT2A
SCHEMBL28845843 0.91 WDR5 (0.86) WDR5KMT2A
SCHEMBL29890884 0.91 WDR5 (0.86) WDR5KMT2A
SCHEMBL24166971 0.90 WDR5 (1.00) WDR5KMT2A
SCHEMBL29544952 0.90 WDR5 (1.00) WDR5KMT2A
SCHEMBL28845798 0.89 WDR5 (0.83) WDR5KMT2A
SCHEMBL24166669 0.89 WDR5 (0.83) WDR5KMT2A
SCHEMBL24166627 0.88 WDR5 (1.00) WDR5KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220152027-A1 ANILINE-BASED WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR, AND PREPARATION METHOD AND USE THEREOF CHINA PHARMACEUTICAL UNIVERSITY (CN) 2022-05-19 US disclosed
EP-3932910-A1 ANILINE WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF China Pharmaceutical University (CN) 2022-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220152027-A1 ANILINE-BASED WDR5 PROTEIN-PROTEIN INTERACTION INHIBITOR, AND PREPARATION METHOD AND USE THEREOF MLLT1, WDR77, MLLT3 WDR5 4/4885KMT2A 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.